GlassScriptPhysician profile
Nishant K Vaidy
NPI 1841510492
$1,513.10
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,513.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $400.69 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $124.99 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $94.58 | 2019 | |
| Viiv Healthcare Company | $90.80 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $88.82 | 2019 | |
| Abbvie INC. | $87.67 | 2019 | |
| Pfizer INC. | $77.80 | 2019 | |
| Amgen INC. | $68.96 | 2019 | |
| Amarin Pharma, INC. | $66.35 | 2019 | |
| Lilly USA, LLC | $60.84 | 2019 | |
| Glaxosmithkline, LLC. | $60.82 | 2019 | |
| Janssen Biotech, INC. | $48.17 | 2019 | |
| Napo Pharmaceuticals INC | $42.55 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $34.71 | 2019 | |
| Merck Sharp & Dohme LLC | $34.36 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $30.20 | 2019 | |
| Bausch Health US, LLC | $29.46 | 2019 | |
| Sanofi Pasteur INC. | $24.38 | 2019 | |
| Shire North American Group INC | $17.14 | 2019 | |
| Arbor Pharmaceuticals, INC. | $15.86 | 2019 | |
| Aytu Biopharma, INC. | $13.95 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nishant Vaidy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.